Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 25, 2016 - Issue 7
Submit an article Journal homepage
389
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluation

Capecitabine for treating head and neck cancer

Hassan IqbalDepartment of Otolaryngology – Head and Neck Surgery, The Ohio State University Wexner Medical Center and Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
&
Quintin PanDepartment of Otolaryngology – Head and Neck Surgery, The Ohio State University Wexner Medical Center and Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USACorrespondence[email protected]
Pages 851-859 | Received 23 Nov 2015, Accepted 19 Apr 2016, Published online: 09 May 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Federica Tomao, Giuseppe Caruso, Lucia Musacchio, Violante Di Donato, Maria Cristina Petrella, Monica Verrico, Silverio Tomao, Pierluigi Benedetti Panici, Ludovico Muzii & Innocenza Palaia. (2021) Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option?. Expert Opinion on Drug Safety 20:6, pages 641-650.
Read now

Articles from other publishers (8)

Camil Ciprian Mireștean, Roxana Irina Iancu & Dragoș Petru Teodor Iancu. (2022) Capecitabine—A “Permanent Mission” in Head and Neck Cancers “War Council”?. Journal of Clinical Medicine 11:19, pages 5582.
Crossref
Ruichen Li, Lulu Ye, Yi Zhu, Hao Ding, Shengzi Wang, Hongmei Ying, Chunping Wu, Liang Zhou, Xiaoshen Wang & Shu Tian. (2022) Induction chemotherapy of modified docetaxel, cisplatin, 5‐fluorouracil for laryngeal preservation in locally advanced hypopharyngeal squamous cell carcinoma. Head & Neck 44:9, pages 2018-2029.
Crossref
Wang-Zhong Li, Xing Lv, Dan Hu, Shu-Hui Lv, Guo-Ying Liu, Hu Liang, Yan-Fang Ye, Wen Yang, Han-Xiong Zhang, Tai-Ze Yuan, De-Shen Wang, Nian Lu, Liang-Ru Ke, Wu-Bing Tang, Li-Hua Tong, Zhi-Jie Chen, Ting Liu, Ka-Jia Cao, Hao-Yuan Mo, Ling Guo, Chong Zhao, Ming-Yuan Chen, Qiu-Yan Chen, Pei-Yu Huang, Rui Sun, Fang Qiu, Dong-Hua Luo, Lin Wang, Yi-Jun Hua, Lin-Quan Tang, Chao-Nan Qian, Hai-Qiang Mai, Xiang Guo, Yan-Qun Xiang & Wei-Xiong Xia. (2022) Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma. JAMA Oncology 8:5, pages 706.
Crossref
Ying Gao, Zhe Liu & Yiting Liu. (2021) Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects. World Journal of Surgical Oncology 19:1.
Crossref
Zilin Zhang, Kai Ma, Jing Li, Yeneng Guan, Chaobo Yang, Aqin Yan & Hongda Zhu. (2021) The Clinical Value of Chemotherapy Combined With Capecitabine in Triple-Negative Breast Cancer—A Meta-Analysis. Frontiers in Pharmacology 12.
Crossref
Jingjing Sha, Yunpeng Bai, Huy Xuan Ngo, Tatsuo Okui & Takahiro Kanno. (2021) Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition. Biomolecules 11:6, pages 893.
Crossref
Seyed Ali Mosaddad, Kimia Beigi, Tayebeh Doroodizadeh, Maral Haghnegahdar, Farzaneh Golfeshan, Reza Ranjbar & Hamid Tebyanian. (2021) Therapeutic applications of herbal/synthetic/bio-drug in oral cancer: An update. European Journal of Pharmacology 890, pages 173657.
Crossref
Cory D. Fulcher, Missak HaigentzJrJr & Thomas J. Ow. (2018) AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma. Head & Neck 40:4, pages 676-686.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.